p53 protein expression in conjunctival squamous cell carcinomas of domestic animals

Veterinary Ophthalmology

Volumn 2, Issue 4, 1999, Pages 227-231

  Sironi, Giuseppe ^a,c   Riccaboni, Pietro ^a   Mertel, Luca ^a   Cammarata, Giorgio ^a   Brooks, Dennis E ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FLORIDA   (United States)

^c Inst Anat Patalogica V   (Italy)

Author keywords

Cat; Cattle; Conjunctival squamous cell carcinoma; Dog; Horse; p53 protein

Indexed keywords

ANIMALIA; BOS TAURUS; BOVINAE; CANIS FAMILIARIS; EQUIDAE; EQUUS CABALLUS; FELIDAE; FELIS CATUS;

EID: 1342272651     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-5224.1999.00086.x     Document Type: Article

References (34)

1. Wilcock BP. The eye and ear. In: Pathology of Domestic Animals 4th edn (eds Jubb KVF, Kennedy PC, Palmer N) Academic Press, San Diego, 1993; 441-529.
2. Miller TR, Gelatt KN. Food animal ophthalmology. In: Veterinary Ophthalmology 2nd edn (ed. Gelatt KN). Lea and Febiger, Philadelphia, 1991; 611-655.
3. Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva. British Journal of Cancer 1996; 74: 1511-1513.
4. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis and tumor promotion. Journal of Investigative Dermatology, Symposium Proceedings 1996; 1: 136-142.
5. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 1991; 51: 6304-6311.
6. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
7. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D. The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. British Journal of Cancer 1994; 69: 409-416.
8. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-679.
9. Lane DP. The regulation of p53 function: Steiner award lecture. International Journal of Cancer 1994; 57: 623-627.
10. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunocytochemistry? - revisited. Journal of Pathology 1994; 172: 1-4.
11. Dequiedt F, Kettmann R, Burny A, Willems L. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep. Virology 1995; 209: 676-683.
12. Devilee P, Van Leeuver IS, Vaesler A, Rutteman GR, Cornelisse CJ. The canine p53 gene is subjected to somatic mutation in thyroid gland. Anticancer Research 1994; 14: 2039-2046.
13. Mayr B, Heczko U, Schellander K, Schleger W, Reifinger M. Sequence of an exon of the feline p53 gene. Mutation in a lymphosarcoma. British Veterinary Journal 1993; 149: 387-390.
14. Mayr B, Schellander K, Schleger W, Reifinger M. Sequence of an exon of the canine p53 gene. Mutation in a papilloma. British Veterinary Journal 1994; 150: 81-84.
15. Mayr B, Schaffner G, Kurzbauer R, Schneider A, Reifinger M, Loupal G. Mutation in tumour suppressor gene p53 in two feline fibrosarcomas. British Veterinary Journal 1995; 151: 707-713.
16. Teifke JP, Löhr CV. Immunohistochemical detection of p53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs. Journal of Comparative Pathology 1996; 114: 205-210.
17. Johnston HM, Thompson H, Pirie HM. p53 immunohistochemistry in domestic animal tumours. European Journal of Veterinary Pathology 1996; 2: 135-140.
18. a Conferenza nazionale su: Stato dell'arte delle ricerche italiane nel settore delle biotecnologie applicate alle scienze veterinarie e zootecniche. Milano, 22 Aprile 1994. Quaderni della Fondazione Iniziative Zooprofilattiche e Zootecniche 1995; 37: 125-135.
19. Cattoretti G, Pileri G, Parravicini C et al. Antigen unmasking on formalin fixed, paraffin embedded tissue sections. Journal of Pathology 1993; 171: 83-98.
20. Vojtesek B, Bártek J, Midgley CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53. Journal of Immunological Methods 1992; 151: 237-244.
21. Vojtesek B, Dolezalova H, Lauerova L, Svitakova M, Havlis P, Kovarik J, Midgley CA, Lane DP. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. Oncogene 1995; 10: 389-393.
22. Pazzi KA, Kraegel SA, Griffey SM, Theon AP, Madewell BR. Analysis of the equine tumor suppressor gene p53 in the normal horse and in eight cutaneous squamous cell carcinomas. Cancer Letters 1996; 107: 125-130.
23. Calzolari A, Mincione F, Messerini L, Parducci V, Giannelli E, Mincione G. p53 protein overexpression in a case of conjunctival micro-invasive carcinoma. European Journal of Ophthalmology 1994; 4: 184-186.
24. Dushku N, Reid TW. p53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Current Eye Research 1997; 16: 1179-1192.
25. Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. American Journal of Ophthalmology 1997; 123: 404-405.
26. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO Journal 1990; 9: 1595-1602.
27. Blagosklonny MV. Loss of function and p53 protein stabilization. Oncogene 1997; 15: 1889-1893.
28. Gazzeri S, Brambilla E, Caron de Fromentel C, Gouyer V, Moro D, Perron P, Berger F, Brambilla C. p53 genetic abnormalities and myc activation in human lung carcinoma. International Journal of Cancer 1994; 58: 24-32.
29. Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H, Rath FW. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma. Identification of seven mutations for soft tissue sarcoma. Cancer 1995; 76: 1187-1196.
30. Sagartz JE, Bodley WL, Gamblin RM, Couto CG, Tierney LA, Capen CC. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Veterinary Pathology 1996; 33: 213-221.
31. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S. Pancreatic adenocarcinomas frequently show p53 gene mutations. American Journal of Pathology 1993; 142: 1534-1543.
32. Dowell SP, Hall PA. The clinical relevance of the p53 tumour suppressor gene. Cytopathology 1994; 5: 144-145.
33. Nelson MA, Einspahr JG, Alberts DS et al. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cancers. Cancer Letters 1994; 85: 23-29.
34. Taguchi M, Watanabe S, Yashima K, Murakami Y, Sekiya T, Ikeda S. Aberrations of the tumor suppressor gene and p53 protein in solar keratosis in human skin. Journal of Investigative Dermatology 1994; 103: 500-503.